Nebula Research & Development’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
60,665
+3,533
| +6% | +$23K | 0.03% | 704 |
|
|
2025
Q1 | $453K | Buy |
57,132
+37,328
| +188% | +$296K | 0.04% | 638 |
|
|
2024
Q4 | $251K | Buy |
19,804
+9,697
| +96% | +$123K | 0.03% | 754 |
|
|
2024
Q3 | $141K | Buy |
+10,107
| New | +$141K | 0.02% | 858 |
|
|
2024
Q2 | – | Sell |
-19,419
| Closed | -$321K | – | 847 |
|
|
2024
Q1 | $321K | Buy |
+19,419
| New | +$321K | 0.07% | 507 |
|
|
2023
Q3 | – | Sell |
-12,380
| Closed | -$148K | – | 533 |
|
|
2023
Q2 | $148K | Buy |
+12,380
| New | +$148K | 0.11% | 286 |
|